Advertisement

ASO Author Reflections: Hepatic Artery Infusion (HAI) Chemotherapy is Associated with Improved Survival Compared with Radioembolization (Y90) in Patients with Isolated Unresectable Colorectal Liver Metastases

  • Mashaal Dhir
  • Amer H. Zureikat
ASO Author Reflections

Notes

Disclosure

The authors have no conflicts of interest to disclose.

References

  1. 1.
    Hickey R, Lewandowski RJ, Prudhomme T, et al. 90Y radioembolization of colorectal hepatic metastases using glass microspheres: safety and survival outcomes from a 531-patient multicenter study. J Nucl Med. 2016;57(5):665–71.CrossRefGoogle Scholar
  2. 2.
    Dhir M, Jones HL, Shuai Y, et al. Hepatic arterial infusion in combination with modern systemic chemotherapy is associated with improved survival compared with modern systemic chemotherapy alone in patients with isolated unresectable colorectal liver metastases: a case–control study. Ann Surg Oncol. 2017;24(1):150–8.CrossRefGoogle Scholar
  3. 3.
    Dhir M, Zenati MS, Jones HL, et al. Effectiveness of hepatic artery infusion (HAI) versus selective internal radiation therapy (Y90) for pretreated isolated unresectable colorectal liver metastases (IU-CRCLM). Ann Surg Oncol. 2018;25(2):550–7.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  1. 1.Division of Surgical Oncology, Department of SurgerySUNY Upstate Medical UniversitySyracuseUSA
  2. 2.Division of Surgical Oncology, Department of SurgeryUniversity of Pittsburgh Medical CenterPittsburghUSA

Personalised recommendations